Hemp & Health Full Year 2022 Earnings: zł0.04 loss per share (vs zł0.019 loss in FY 2021)

Simply Wall St

February 20, 2023

Hemp & Health (WSE:HMP) Full Year 2022 Results

Key Financial Results

Revenue: zł1.07m (down 57% from FY 2021).
Net loss: zł2.89m (loss widened by 423% from FY 2021).
zł0.04 loss per share (further deteriorated from zł0.019 loss in FY 2021).

earnings-and-revenue-history — WSE:HMP Earnings and Revenue History February 20th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Hemp & Health shares are down 11% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 4 warning signs for Hemp & Health that you need to be mindful of.

If you're looking to trade Hemp & Health, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Valuation is complex, but we're here to simplify it.

Discover if Hemp & Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.